Distinctive Microbial Signatures and Gut-Brain Crosstalk in Pediatric Patients with Coeliac Disease and Type 1 Diabetes Mellitus

Autor: Mamoun Elawad, Bara Al-Jarrah, Hoda Gad, Souhaila Al Khodor, Mohammed A. Hendaus, Khalid Hussain, Rayaz A. Malik, Anthony K Akobeng, Arun Rawat, Wesam Almasri, Saras Saraswathi, Parul Singh
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Pilot Projects
Gut flora
medicine.disease_cause
Coeliac disease
lcsh:Chemistry
Cornea
Pathogenesis
0302 clinical medicine
T1DM
Shigella
Child
lcsh:QH301-705.5
Spectroscopy
biology
Brain
General Medicine
Amplicon
Computer Science Applications
Trigeminal Nerve Diseases
corneal confocal microscopy
030211 gastroenterology & hepatology
Adolescent
pediatric neuropathy
Article
Catalysis
Inorganic Chemistry
03 medical and health sciences
children
Escherichia coli
medicine
Humans
Physical and Theoretical Chemistry
Molecular Biology
Type 1 diabetes
gut microbiota
Bacteroidetes
Organic Chemistry
medicine.disease
biology.organism_classification
Gastrointestinal Microbiome
Celiac Disease
Cross-Sectional Studies
Diabetes Mellitus
Type 1

030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Immunology
Dysbiosis
coeliac disease
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 1511, p 1511 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms22041511
Popis: Coeliac disease (CD) and Type 1 diabetes mellitus (T1DM) are immune-mediated diseases. Emerging evidence suggests that dysbiosis in the gut microbiome plays a role in the pathogenesis of both diseases and may also be associated with the development of neuropathy. The primary goal in this cross-sectional pilot study was to identify whether there are distinct gut microbiota alterations in children with CD (n = 19), T1DM (n = 18) and both CD and T1DM (n = 9) compared to healthy controls (n = 12). Our second goal was to explore the relationship between neuropathy (corneal nerve fiber damage) and the gut microbiome composition. Microbiota composition was determined by 16S rRNA gene sequencing. Corneal confocal microscopy was used to determine nerve fiber damage. There was a significant difference in the overall microbial diversity between the four groups with healthy controls having a greater microbial diversity as compared to the patients. The abundance of pathogenic proteobacteria Shigella and E. coli were significantly higher in CD patients. Differential abundance analysis showed that several bacterial amplicon sequence variants (ASVs) distinguished CD from T1DM. The tissue transglutaminase antibody correlated significantly with a decrease in gut microbial diversity. Furthermore, the Bacteroidetes phylum, specifically the genus Parabacteroides was significantly correlated with corneal nerve fiber loss in the subjects with neuropathic damage belonging to the diseased groups. We conclude that disease-specific gut microbial features traceable down to the ASV level distinguish children with CD from T1DM and specific gut microbial signatures may be associated with small fiber neuropathy. Further research on the mechanisms linking altered microbial diversity with neuropathy are warranted.
Databáze: OpenAIRE